API | menopausal gonadotropin

menopausal gonadotropin Report issue

Biological Experimental

AACT ChEMBL

Active Ingredient History

NOW

Menotropin is a hormonally active medication for the treatment of fertility disturbances. Frequently the plural is used as the medication is a mixture of gonadotropins. Menotropins are extracted from the urine of postmenopausal women. ^Wikipedia

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecule:
menotropins

More Chemistry

Pharmacology

Mechanism of Action:
- Follicle-stimulating hormone receptor (Homo sapiens) ^UniProt
Multi-specific: Missing data
Black Box: No
Availability: Prescription Only
Delivery Methods: Parenteral
Pro Drug: No

human menopausal gonadotropin | menopausal gonadotropin | menopur

Organizations (32)

Research & Development (32)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (11)

Approved Indications (1)

Infertility

Experimental Indications - Clinical Trial Phases 1-4 (11)

Endocrine System Diseases (Phase 1/Phase 2)

Fertilization in Vitro (Phase 4)

Gonadal Disorders (Phase 1/Phase 2)

Hypogonadism (Phase 4)

Infertility (Phase 4)

Kallmann Syndrome (Phase 4)

Ovarian Reserve (Phase 4)

Ovulation Induction (Phase 4)

Polycystic Ovary Syndrome (Phase 4)

Reproductive Health (Phase 4)

Sperm Injections, Intracytoplasmic (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 33
# of Trial Organizations: 32

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue